Physician profile
Patrick Zito
NPI 1689052748
$1,915.33
in general payments reported to CMS, 2019-2025
19 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $90.50 · 2021: $82.96 · 2023: $208 · 2024: $249 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $435.84 | 2023-2025 | |
| Allergan, INC. | $246.96 | 2019 | |
| Abbvie INC. | $238.80 | 2019-2021 | |
| Organogenesis INC. | $147.36 | 2023-2024 | Puraply, Affinity, Cygnus Dual |
| Lilly USA, LLC | $138.52 | 2019-2020 | |
| Almirall LLC | $118.94 | 2019 | |
| Galderma Laboratories, L.P. | $113.65 | 2019 | |
| Pfizer INC. | $107.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $63.50 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $55.21 | 2021-2024 | Libtayo |
| Kerecis Limited | $49.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Incyte Corporation | $47.49 | 2024-2025 | Opzelura |
| Verrica Pharmaceuticals INC. | $40.95 | 2023-2024 | Ycanth |
| Amgen INC. | $27.58 | 2019 | |
| Smith+Nephew, INC. | $23.38 | 2024 | Pico 14 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.73 | 2019 | |
| Celgene Corporation | $16.05 | 2019 | |
| Sebela Pharmaceuticals INC. | $14.21 | 2021 | |
| Paratek Pharmaceuticals, INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Zito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.